In brief
Rebel factions in Syria have uncovered widespread stockpiles of Captagon, an illegal amphetamine pivotal to the country's burgeoning drug trade, financed by connections to the former Assad government. As international scrutiny grows, questions remain about the future of Syria's narcotics market and the incoming leadership's approach to curbing this crisis.
Rebel factions in Syria have recently discovered extensive stockpiles of Captagon, an illegal amphetamine, in a warehouse in Damascus. This find points to a broader narcotics-trafficking scheme allegedly orchestrated by affiliates of the ousted President Bashar al-Assad, shifting the nation’s focus from traditional exports to a booming illegal drug industry.Captagon, known as fenethylline in its earlier legal form, was originally synthesized in Germany to treat conditions such as ADHD, depression, and narcolepsy. However, following its ban in most countries during the 1980s due to its highly addictive nature and severe side effects—including psychosis and suicidal tendencies—its illicit version has emerged as a popular stimulant across the Middle East. This current form often comprises a mixture of amphetamines and caffeine, produced cheaply in Syria for minimal costs, yet selling for substantial amounts between $3 to $20 per pill on the streets.Recent revelations have shown how deep the connections run between the drug trade and the fallen Assad regime, indicating a highly organized, though illegal, business model that has outstripped Syria’s legal exports. The advent of new leadership in the country raises pertinent questions: How will they address this rampant issue? Will there be a concerted effort to dismantle the narcotics networks that have flourished during years of conflict?As the situation continues to unfold, the balance of power within the drug market and its socio-economic impacts on the region remain critical topics of inquiry for both local and global observers.
